Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS.

Hamid, U

Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS. [electronic resource] - Thorax 11 2017 - 971-980 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1468-3296

10.1136/thoraxjnl-2016-208571 doi


Adult
Anti-Inflammatory Agents, Non-Steroidal--therapeutic use
Aspirin--therapeutic use
Biomarkers--metabolism
Bronchoalveolar Lavage
C-Reactive Protein--immunology
Cytokines--immunology
Double-Blind Method
Female
Humans
Inflammation--drug therapy
Inhalation
Interleukin-8--immunology
Lipopolysaccharides--administration & dosage
Male
Neutrophils--immunology
Prospective Studies
Respiratory Distress Syndrome--diagnosis
Treatment Outcome
Volunteers